Pediatric Allergic Contact Dermatitis: Clinical and Epidemiological Study in a Tertiary Hospital

J M Ortiz Salvador1, A Esteve Martínez1, D Subiabre Ferrer1

  • 1Servicio de Dermatología, Consorcio Hospital General Universitario de Valencia, Valencia, España.

Insights

Over half of children suspected of allergic contact dermatitis show sensitization to allergens. Early diagnosis and patch testing are crucial for effective management in pediatric cases.

Area of Science:

  • Dermatology
  • Pediatrics
  • Epidemiology

Background:

  • Limited epidemiological data exists on childhood allergic contact dermatitis.
  • Underdiagnosis is common due to low clinical suspicion and infrequent patch testing.
  • Pediatric sensitization rates to allergens can be as high as 20%.

Purpose of the Study:

  • To investigate the incidence and patterns of allergic contact dermatitis in children.
  • To identify common allergens causing sensitization in pediatric patients.
  • To emphasize the importance of patch testing in diagnosing childhood allergic contact dermatitis.

Main Methods:

  • Retrospective analysis of a dermatology department's skin allergy database (2000-2015).
  • Inclusion of children aged 0-16 years diagnosed with allergic contact dermatitis.
  • Collection of epidemiological and clinical data, including patch test results.

Main Results:

  • Patch tests were performed on 265 children (6% of total patients).
  • 54.3% of children showed positive reactions to at least one allergen.
  • Most frequent allergens included thiomersal, cobalt chloride, colophony, and paraphenylenediamine.

Conclusions:

  • Over half of the pediatric patients exhibited sensitization to one or more allergens.
  • A significant percentage of these sensitizations were clinically relevant.
  • Patch testing is recommended for all children with suspected allergic contact dermatitis, with careful allergen selection.
Abstract

Related Concept Videos

Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
92
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
80
Allergic Reactions02:06

Allergic Reactions

Overview
33.1K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
342
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
615